Location & Type arrow_drop_up Concepts arrow_drop_down Orgs arrow_drop_down
#1
Cancer Biotherapy Research Group
Cancer Biotherapy Research Group
Known for star star star star star
Monoclonal Antibody | Cancer Cells | Autologous Tumor | Chronic Lymphocytic
#2
ROBERT O. DILLMAN
ROBERT O. DILLMAN
Known for star star star star star
Monoclonal Antibody | Autologous Tumor | Indolent Lymphoma | Interferon Alfa

#3
Gianluca Gaidano
Gianluca Gaidano
Division of Hematology, BRMA - Amedeo Avogadro Unversity of Eastern Piedmont, Novara, Italy
Known for star star star star star_half
Mcl0208 Trial | Rituximab Lenalidomide | Lymphoid Leukemia | Richter Transformation
#4
Meibergdreef 9, F4-224
Meibergdreef 9, F4-224
Known for star star star star star_border
Follicular Lymphoma | Bendamustine Lenalidomide | Rituximab Phase | Primary Endpoints
#5
Stichting Hemato-Oncologie voor Volwassenen Nederl
Stichting Hemato-Oncologie voor Volwassenen Nederl
Known for star star star star star_border
Stem Cells | Follicular Lymphoma | Chronic Lymphocytic | Sibling Donors
#6
Maria Alma Rodriguez
Maria Alma Rodriguez
Division of Medicine, Lymphoma Section, University of Texas M. D. Anderson Cancer Center, Houston, Texas
Known for star star star star star_border
Radiation Therapy | Follicular Lymphoma | Response Rate | Denileukin Diftitox
#7
Jason Robert Westin
Jason Robert Westin
Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Unit 429, 1515 Holcombe Blvd, 77030, Houston, TX, USA
Known for star star star star star_border
Advisory Committees | Entitys Board | B-Cell Lymphoma | Speakers Bureau
#8
Krimo Bouabdallah
Krimo Bouabdallah
CHU Bordeaux, Service d’Hématologie et Thérapie Cellulaire, Bordeaux, France
Known for star star star star star_border
Advisory Committees | Entitys Board | Speakers Bureau | Intensive Chemotherapy
#9
Julia Grunert
Julia Grunert
Bayer Pharma AG, Aprather Weg 18, 42096 Wuppertal, Germany
Known for star star star star star_border
Aggressive Lymphoma | Levonorgestrel Intrauterine | Pi3k Inhibitor | Metastatic Colorectal Cancer
#10
David A. MacDonald
David A. MacDonald
The Ottawa Hospital, University of Ottawa, Ottawa, Ontario, Canada.
Known for star star star star star_border
Follicular Lymphoma | Subcutaneous Rituximab | Speakers Bureau | Inotuzumab Ozogamicin
#11
Forrest Swan
Forrest Swan
University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
Known for star star star star star_border
Flow Cytometry | Low-Grade Lymphoma | Combination Chemotherapy | Response Rate
#12
Andreas Draube
Andreas Draube
University of Cologne, Department of Internal Medicine I, Cologne, Germany
Known for star star star star star_border
Bone Marrow | Nude Mice | Platelet Contamination | High-Dose Chemotherapy
#13
Steve Dahlberg
Steve Dahlberg
Loyola University, Chicago, IL, USA
Known for star star star star star_border
Southwest Oncology | Marrow Transplantation | Severe Aplastic Anemia | Ovarian Cancer
#14
On Behalf Of The Nordic Lymphoma Group
On Behalf Of The Nordic Lymphoma Group
Known for star star star star star_border
Nordic Lymphoma | Single Agent | Long-Term Molecular Remissions | Extended Rituximab
#15
Dana Shelton Thompson
Dana Shelton Thompson
Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN; Nebraska Methodist Hospital Cancer Center, Omaha, NE; Northeast Georgia Medical Center, Gainesville, GA
Known for star star star star star_border
Unknown Primary Site | Weekly Docetaxel | Advanced Malignancies | Sarah Cannon
#16
David R. Trevarthen
David R. Trevarthen
Department of Hematology/Oncology, Comprehensive Cancer Care and Research Institute of Colorado, Englewood, Colorado.
Known for star star star star star_border
Induction Chemotherapy | Advisory Committees | Entitys Board | Reduced-Dose Imrt
#17
E. Ellen Shrader
E. Ellen Shrader
Authors' Affiliations: Massey Cancer Center; Departments of Internal Medicine, Biostatistics, Microbiology and Immunology, and Biochemistry and Molecular Biology, and The ...
Known for star star star star star_border
Indolent B-Cell Lymphoma | Advanced Solid Tumors | Acute Leukemia | Myelodysplastic Syndrome

 

Recently Asked Questions

View all FAQs

Interstitial Pneumonia Interstitial pneumonia is a type of lung disease that occurs when the tissue between the alveoli (air sacs) becomes inflamed. This inflammation can cause...

 

Palmoplantar Psoriasis Palmoplantar psoriasis is a form of psoriasis that affects the palms of the hands and the soles of the feet. It can cause the skin to become thick, scaly,...

 

Pancoast Tumor Pancoast tumors are a type of cancer that develops in the upper lung. The tumor gets its name from the fact that it grows near the top of the lung, near the...

 

Adrenal Adenoma An adrenal adenoma is a type of tumor that develops in the adrenal gland. The adrenal gland is a small organ located on top of each kidney, and it produces...

 

Diaphragmatic endometriosis is a condition in which the tissue that normally lines the uterus (endometrium) grows outside of the uterus, on the diaphragm....

 

Rituximab Anti-Cd20 Monoclonal Antibody Plus Oral Cyclophosphamide As Initial...

[ CLINICAL_TRIAL ] ... have indolent stage III or stage IV non-Hodgkin's lymphoma. Detailed Description OBJECTIVES: I. Determine the toxicity associated with cyclophosphamide and rituximab (IDEC-C2B8 monoclonal ...
Known for star star star star star
Indolent Lymphoma | Monoclonal Antibody | Oral Cyclophosphamide | Cancer Cells

Rebel Study: A Randomized Phase I/ii Trial Of Lenalidomide And Rituximab With Or...

[ CLINICAL_TRIAL ] ... an indolent type of lymphoma. After diffuse large B cell lymphoma, it is the most frequently occurring type of lymphoma. In the Netherlands, 800 new cases are diagnosed yearly. Although ...
Known for star star star star star
Follicular Lymphoma | Lenalidomide Rituximab | Toxicity Phase | Primary Endpoints

Phase Ii Study Of Gemcitabine In Patients With Advanced Stage Marginal Zone...

[ CLINICAL_TRIAL ] ... the indolent lymphoma, is believed to be incurable with chemotherapy. Thus the investigators need a novel agent for marginal zone lymphoma. Gemcitabine has been tried as one of salvage ...
Known for star star star star star_half
Marginal Zone | Lymphoma Gemcitabine | Advanced Stage | Chemotherapy Agent

Phase Ii Trial Of Everolimus (Rad001) In Relapsed/refractory Lymphoma. Everolimus...

[ CLINICAL_TRIAL ] ... with lymphoma that has relapsed or not responded to previous treatment. Detailed Description OBJECTIVES:PrimaryAssess the tumor response in patients with relapsed or refractory indolent ...
Known for star star star star star_half
Everolimus Lymphoma | Closed Accrual | Growth Cancer | Blocking Blood

An Open-Label Phase 2 Trial Of Acalabrutinib Plus Obinutuzumab In Patients With...

[ CLINICAL_TRIAL ] ... other indolent non-Hodgkin lymphoma for which the patient has not received treatment in the past (previously untreated). Acalabrutinib may stop the growth of cancer cells by blocking some ...
Known for star star star star star_half
Follicular Lymphoma | Acalabrutinib Obinutuzumab | Phase Cycle | Indolent Hodgkin

A Phase Ii Trial To Evaluate The Rate Of Immune Response Using Idiotype...

[ CLINICAL_TRIAL ] ... non-Hodgkin's lymphoma. Detailed Description OBJECTIVES: I. Determine the ability of recombinant idiotype immunotherapy to stimulate a specific immune response against the B cell idiotype ...
Known for star star star star star_border
Immune Response | Tumor Cells | Idiotype Immunotherapies | Molecular Biological

A Phase I Trial Of Obinutuzumab In Combination With Venetoclax In Previously...

[ CLINICAL_TRIAL ] Follicular lymphoma (FL) is an indolent yet incurable lymphoma characterized by initial responses to standard therapies, invariably followed by shorter disease free intervals. Obinutuzumab, a ...
Known for star star star star star_border
Follicular Lymphoma | Combination Obinutuzumab | Cll Trial | Single Agent

A Phase I, Dose-Escalation Trial Of Rituxan And Bendamustine In Combination With...

[ CLINICAL_TRIAL ] ... non-Hodgkin lymphoma (NHL). BTK inhibitor PCI-32765 may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as rituximab, ...
Known for star star star star star_border
Bendamustine Pci-32765 | Btk Inhibitor | Escalation Trial | Cancer Cells

A Phase I/iia Trial For The Treatment Of Relapsed Or Chemotherapy Refractory...

[ CLINICAL_TRIAL ] RATIONALE: Using T cells from the patient that have been treated in the laboratory may help the body build an effective immune response to kill cancer cells. Drugs used in chemotherapy, such as ...
Known for star star star star star_border
Antigen Cd19 | Cells Genetically | Iia Trial | Modified 28z

A Global Multicenter Phase 1/2 Trial Of Eo2463, A Novel Microbial-Derived Peptide...

[ CLINICAL_TRIAL ] ... Lymphoma
Known for star star star star star_border
Hodgkins Lymphoma | Peptide Therapeutic | Multicenter Phase | Marginal Zone